Medicare Enrolled
Dr. Jared Mataska, M.D.
Family Medicine · Graham, TX
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Mataska from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Mataska?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Mataska
Dr. Jared Mataska is a family medicine specialist in Graham, TX, with 9 years of NPI registration. Based on federal Medicare data, Dr. Mataska performed 9,777 Medicare services across 5,465 unique beneficiaries.
Between the years covered by Open Payments, Dr. Mataska received a total of $2,285 from 30 pharmaceutical and/or device companies across 141 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in family medicine. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Mataska is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 9 years in practice
▲ Top 1% volume in TX
$2,285 industry payments
Medicare Practice Summary
Medicare Utilization ↗9,777
Medicare services
Top 1% in TX for family medicine
5,465
Unique beneficiaries
$35
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~1,086 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Denosumab injection (Prolia/Xgeva) | 1,200 | $18 | $30 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
920 | $82 | $250 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
595 | $8 | $20 |
| Complete blood count (CBC) with differential An automated laboratory test that measures the levels of red blood cells, white blood cells, and platelets in the blood, including a breakdown of the different types of white blood cells. |
583 | $8 | $40 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
547 | $59 | $170 |
| Comprehensive metabolic blood panel A blood test that measures a group of chemicals, including glucose, electrolytes, and kidney and liver function markers. |
542 | $10 | $70 |
| Lipid panel (cholesterol and triglycerides) A blood test that measures cholesterol and triglyceride levels. |
483 | $13 | $100 |
| Chronic care management, first 20 min/month This service covers the first 20 minutes of clinical staff time directed by a healthcare professional each calendar month to manage chronic conditions. |
401 | $47 | $122 |
| Betamethasone steroid injection An injection containing a combination of betamethasone acetate and betamethasone sodium phosphate. |
390 | $4 | $25 |
| Advance care planning consultation, first 30 min A session focused on discussing and documenting future healthcare preferences and goals. This service covers the initial 30 minutes of the planning discussion. |
300 | $76 | $253 |
| Annual alcohol misuse screening, 5 to 15 minutes | 297 | $18 | $53 |
| Annual depression screening | 280 | $18 | $75 |
| Annual wellness visit, follow-up A follow-up annual wellness visit that includes a personalized prevention plan of service. |
273 | $123 | $275 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
271 | $9 | $55 |
| Chest X-ray, 2 views An X-ray imaging test of the chest that captures two different angles to visualize the lungs, heart, and chest wall. |
235 | $21 | $95 |
| Infectious disease DNA/RNA test A laboratory test that uses a specific technique to detect the genetic material of an organism. This method amplifies the target DNA or RNA to identify the presence of the organism. |
224 | $34 | $100 |
| Hemoglobin A1c test (diabetes monitoring) A blood test that measures your average blood sugar levels over the past two to three months. |
189 | $10 | $60 |
| Bone density scan (DEXA) A test that uses low-dose X-rays to measure bone mineral density in the hip, pelvis, and spine. It helps assess bone strength and risk of fractures. |
158 | $36 | $335 |
| Remote patient monitoring management, 20 min/month Management based on results from remote vital sign monitoring for the first 20 minutes per calendar month. |
142 | $35 | $149 |
| Home health agency supervision, complex multidisciplinary care Supervision by a physician or allowed practitioner for a patient receiving Medicare-covered services from a participating home health agency. This involves complex and multidisciplinary care modalities, with the patient not present during the supervision. |
131 | $78 | $125 |
| Urinalysis with microscopic exam A urine test performed manually that includes examining the sample under a microscope to check for abnormalities. |
118 | $3 | $35 |
| Respiratory virus nucleic acid test, 3-5 targets A laboratory test that uses nucleic acid detection to identify multiple types or subtypes of respiratory viruses. The test analyzes 3 to 5 specific viral targets. |
113 | $140 | $1,100 |
| COVID-19 viral test, non-CDC A laboratory test to detect the SARS-CoV-2 virus (COVID-19) using any technique and targeting multiple types or subtypes. This specific code is for tests performed by laboratories that are not the CDC. |
113 | $50 | $100 |
| Chlamydia pneumoniae nucleic acid test A laboratory test that uses amplified probe techniques to detect the genetic material of Chlamydia pneumoniae bacteria in a sample. |
112 | $34 | $100 |
| Mycoplasma pneumoniae nucleic acid test A laboratory test that uses amplified probe techniques to detect the genetic material of Mycoplasma pneumoniae bacteria. |
112 | $34 | $100 |
| Ceftriaxone antibiotic injection This code represents the administration of ceftriaxone sodium, an antibiotic medication. The charge is calculated for every 250 mg of the drug administered. |
104 | $0 | $5 |
| Strep A rapid test A rapid test to detect Group A Streptococcus bacteria using an immunoassay method with direct visual observation. |
87 | $16 | $45 |
| Chronic care management, additional 20 min/month This service covers an extra 20 minutes of clinical staff time directed by a healthcare professional for managing two or more chronic conditions each calendar month. |
80 | $35 | $94 |
| Electrocardiogram (EKG), 12-lead A standard heart rhythm test using at least 12 leads to record electrical activity. A healthcare provider interprets the results and provides a written report. |
76 | $10 | $75 |
| Urine microalbumin test A laboratory test that measures the amount of a specific protein called microalbumin in a urine sample. This analysis helps assess kidney function. |
64 | $6 | $45 |
| Creatinine test (kidney function) A blood test that measures the amount of creatinine to assess kidney function or detect muscle injury. |
64 | $5 | $60 |
| Basic metabolic blood panel A blood test that measures a group of basic chemicals, including total calcium levels. |
60 | $8 | $60 |
| Remote patient monitoring device, 30 days Initial setup of devices for remote monitoring of body functions with daily data transmission or alerts. This service covers the first 30 days of the monitoring period. |
55 | $35 | $177 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
52 | $94 | $385 |
| Remote vital sign monitoring management, each additional 20 minutes This code covers the time spent by a provider managing patient data from remote vital sign monitoring devices. It applies to each additional 20-minute increment beyond the initial monthly service period. |
44 | $30 | $122 |
| Ketorolac injection, per 15 mg An injection of ketorolac tromethamine, a nonsteroidal anti-inflammatory drug, administered in doses measured per 15 mg. |
38 | $0 | $25 |
| X-ray of lower and sacral spine, 2-3 views An X-ray imaging test that captures 2 to 3 views of the lower back and sacral spine to visualize the bones and joints in this area. |
27 | $23 | $110 |
| Knee X-ray, 1-2 views An X-ray imaging test of the knee joint using one to two different angles to visualize the bones and surrounding structures. |
25 | $23 | $97 |
| Transitional care management, high complexity Coordination of care for a patient transitioning from a short-term hospital stay or other facility to home or another care setting. This service addresses a high-complexity medical problem. |
25 | $211 | $520 |
| Echocardiogram, transthoracic An ultrasound of the heart that uses color to show blood flow, rate, direction, and valve function. |
24 | $139 | $608 |
| Ultrasound of arm and leg arteries This procedure uses sound waves to create images of the blood vessels in the arms and legs. It allows healthcare providers to examine the structure and blood flow within these arteries. |
24 | $48 | $246 |
| Follow-up heart ultrasound An ultrasound of the heart performed to monitor or reassess a previously identified condition or treatment progress. |
23 | $54 | $800 |
| Ultrasound of aorta, vena cava, groin vessels or bypass grafts This procedure uses sound waves to create images of the aorta, vena cava, groin vessels, or bypass grafts. It allows for the visualization of these blood vessels and any surgical grafts. |
23 | $82 | $351 |
| Expiratory airflow and volume test A test that measures the amount of air you can exhale and the speed at which you can breathe it out. It evaluates lung function by assessing expiratory airflow and volume. |
21 | $20 | $103 |
| Joint injection, major joint Removal of fluid from a large joint and/or injection of medication into the joint space. |
20 | $50 | $180 |
| Drug test with direct observation A drug screening test performed under direct observation to ensure the sample is provided correctly. This method is used to verify the integrity of the specimen collection process. |
20 | $12 | $100 |
| Natriuretic peptide level test A blood test that measures the level of natriuretic peptide, a protein produced by the heart and blood vessels. |
19 | $38 | $200 |
| Hip X-ray, 2-3 views An X-ray imaging test of the hip joint using two to three different angles to visualize the bones and surrounding structures. |
15 | $31 | $131 |
| Shoulder X-ray, 2+ views An X-ray imaging test of the shoulder joint using at least two different angles to visualize the bones and surrounding structures. |
12 | $22 | $96 |
| Initial preventive physical examination, new Medicare beneficiary A comprehensive preventive health visit for new Medicare beneficiaries during their first 12 months of enrollment. The service is conducted as a face-to-face visit and is limited to preventive care. |
12 | $145 | $489 |
| Routine 12-lead ECG screening A standard 12-lead electrocardiogram performed as part of an initial preventive physical examination. The service includes both the performance of the test and the physician's interpretation and report. |
12 | $8 | $50 |
| Abdominal X-ray, 2 views An X-ray imaging test of the abdomen using two different angles to visualize internal structures. |
11 | $28 | $104 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
11 | $45 | $250 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
0.5% high complexity
21.2% medium
78.3% routine
Industry Payment Transparency
Open Payments through 2024 ↗$2,285
Total received (2018-2024)
Avg $326/year across 7 years
Top 25% in TX for family medicine
30
Companies
141
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$2,285 (100.0%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$689
2023
$657
2022
$377
2021
$120
2020
$201
2019
$181
2018
$59
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Novartis Pharmaceuticals Corporation
$280
Lilly USA, LLC
$255
Novo Nordisk Inc
$246
PFIZER INC.
$209
AstraZeneca Pharmaceuticals LP
$160
ABBVIE INC.
$146
GlaxoSmithKline, LLC.
$139
Amgen Inc.
$123
Boehringer Ingelheim Pharmaceuticals, Inc.
$89
Astellas Pharma US Inc
$87
Janssen Pharmaceuticals, Inc
$56
Biohaven Pharmaceutical Holding Company Ltd.
$51
Bayer Healthcare Pharmaceuticals Inc.
$47
Takeda Pharmaceuticals U.S.A., Inc.
$46
Xeris Pharmaceuticals, Inc.
$44
Tactile Systems Technology Inc
$33
E.R. Squibb & Sons, L.L.C.
$31
Exact Sciences Corporation
$30
Merck Sharp & Dohme Corporation
$29
Otsuka America Pharmaceutical, Inc.
$28
Genentech USA, Inc.
$21
Allergan, Inc.
$20
Bayer HealthCare Pharmaceuticals Inc.
$17
Sumitomo Pharma America, Inc.
$17
Mylan Specialty L.P.
$15
Lundbeck LLC
$15
Abbott Laboratories
$14
IDORSIA PHARMACEUTICALS US INC
$13
Flexion Therapeutics, Inc.
$11
Amarin Pharma Inc.
$11
Top 3 companies account for 34.2% of total payments
Associated products mentioned in payments ›
AIRSUPRA · ANORO ELLIPTA · Aimovig · BELSOMRA · BEXSERO · BREZTRI · COMIRNATY · Cologuard Collection Kit · ELIQUIS · EMGALITY · ENTRESTO · EVENITY · FARXIGA · FLUMIST QUADRIVALENT · FREESTYLE LIBRE · Flexitouch Plus · GEMTESA · GVOKE PFS · INVOKANA · JARDIANCE · Kerendia · LEQVIO · MOUNJARO · NURTEC ODT · Otezla · Ozempic · PREMARIN · PREVNAR 13 · PREVNAR 20 · QULIPTA · QUVIVIQ · RECORLEV · REXULTI · Rybelsus · SHINGRIX · TRELEGY ELLIPTA · TRINTELLIX · TRULICITY · TRUMENBA · Tresiba · UBRELVY · VRAYLAR · VYEPTI · Vascepa · Veozah · XARELTO · Xofluza · Yupelri · Zilretta
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Equivalent to $23 per 100 Medicare services performed
Geographic Context
Family medicine physicians within 10 mi
17
Per 100K population
94.6
County median income
$63,723
Nearest hospital
GRAHAM REGIONAL MEDICAL CENTER
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Mataska is a clinical cardiology specialist, with above-average Medicare volume (top 1% in TX), with low-engagement industry engagement.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Mataska experienced with denosumab injection (prolia/xgeva)?
Based on Medicare claims data, Dr. Mataska performed 1,200 denosumab injection (prolia/xgeva) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Mataska receive payments from pharmaceutical companies?
Yes. Dr. Mataska received a total of $2,285 from 30 companies across 141 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Mataska's costs compare to other family medicine physicians in Graham?
Dr. Mataska's average Medicare payment per service is $35. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Mataska) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Specialty guide
Understanding Family Medicine
Common procedures, typical costs, and what industry payments mean in family medicine.
Same specialty & city
Family Medicine Physicians in Graham
Browse family medicine physicians in Graham ranked by procedure volume and transparency data.
Highest volume
Top Family Medicine Physicians in TX
Family medicine physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Family Medicine Physicians in TX
Which TX family medicine physicians receive the most from drug and device companies.
By company
Novartis Pharmaceuticals Corporation Payments to Doctors
See all physicians who received payments from Novartis Pharmaceuticals Corporation.
By company
Lilly USA, LLC Payments to Doctors
See all physicians who received payments from Lilly USA, LLC.
By company
Novo Nordisk Inc Payments to Doctors
See all physicians who received payments from Novo Nordisk Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology